User profiles for Shreyas S. Joshi

Shreyas Joshi

Proteovant Therapeutics
Verified email at proteovant.com
Cited by 364

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre …

…, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi… - The Lancet, 2021 - thelancet.com
Background Molecular imaging is increasingly used to guide treatment decisions and
planning in prostate cancer. We aimed to evaluate the role of 18 F-fluciclovine-PET/CT in …

[HTML][HTML] Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very …

…, T Horn, P Iranpour, H Jacene, I Jayaratna, SS Joshi… - European urology, 2023 - Elsevier
… ) was approved by each study site’s institutional review board/independent ethics committee…
-site pathologist for the presence or absence of PCa according to the site’s standard of care. …

Increased fragmentation of sleep–wake cycles in the 5XFAD mouse model of Alzheimer's disease

M Sethi, SS Joshi, RL Webb, TL Beckett, KD Donohue… - Neuroscience, 2015 - Elsevier
Sleep perturbations including fragmented sleep with frequent night-time awakenings and
daytime naps are common in patients with Alzheimer’s disease (AD), and these daily …

Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma

…, R Nabavizadeh, S Steele, M Williams, SS Joshi… - Cancer, 2021 - Wiley Online Library
BACKGROUND Body composition and inflammation are gaining importance for prognostication
in cancer. This study investigated the individual and combined utility of the preoperative …

Treatment trends and outcomes for patients with lymph node–positive cancer of the penis

SS Joshi, E Handorf, D Strauss, AF Correa… - JAMA …, 2018 - jamanetwork.com
Importance Penile cancer is an uncommon disease with minimal level I evidence to guide
therapy. The National Comprehensive Cancer Network (NCCN) guidelines advocate a lymph …

Treatment facility volume and survival in patients with metastatic renal cell carcinoma: a registry-based analysis

SS Joshi, EA Handorf, M Zibelman, ER Plimack… - European urology, 2018 - Elsevier
Background Higher treatment facility (TF) volume has been linked with improved oncologic
treatment outcomes. Objective To determine the association between TF volume and overall …

Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in …

…, RG Uzzo, M Haseebuddin, SS Joshi… - BJU …, 2019 - Wiley Online Library
Objectives To develop a clinically applicable predictive model to quantitate the risk of
estimated glomerular filtration rate (eGFR) decline to ≤45 mL/min/1.73 m 2 after radical …

The importance of temperature and thermoregulation for optimal human sleep

SS Joshi, TJ Lesser, JW Olsen, BF O'Hara - Energy and Buildings, 2016 - Elsevier
In the last few decades, there has been a decline in average sleep duration and quality that
has adversely affected general health of the population. Increased use of artificial lighting, …

Baseline modified Glasgow prognostic score associated with survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors

…, GA Russler, S Caulfield, LB Yantorni, SS Joshi… - The …, 2021 - academic.oup.com
Background The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates
albumin and C‐reactive protein, has proven useful in the prognostication of multiple …

Renal tumor anatomic complexity: clinical implications for urologists

SS Joshi, RG Uzzo - Urologic Clinics, 2017 - urologic.theclinics.com
Every patient with a renal mass poses a unique set of circumstances that must be considered
before treatment. Clinically, these may include various demographics, such as age and …